greeksoup/ stock research

Colgate-Palmolive (CL) FY2024 results: revenue $20.1 billion, up 3.3% on the year

Colgate-Palmolive Co. (CL) reported revenue of $20.1 billion for fiscal 2024, the year ended 31 December 2024, up 3.3% on the year before. Net income was $2.9 billion, up 25.6%, and diluted earnings per share $3.51. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2025.

Revenue
$20.1 billion
+3.3% on the year
FY2017FY2024
Operating margin
21.2%
20.5% a year earlier
FY2017FY2024
Net income
$2.9 billion
+25.6% on the year
FY2017FY2024
Diluted EPS
$3.51
+26.7% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue20,10119,45717,967+3.3%
Cost of revenue7,9408,1317,719-2.3%
Gross profit12,16111,32610,248+7.4%
Gross margin60.5%58.2%57.0%
Research and development355343320+3.5%
Selling, general and administrative7,7297,1516,565+8.1%
Operating income4,2683,9842,893+7.1%
Operating margin21.2%20.5%16.1%
Interest expense292287167+1.7%
Pre-tax income3,9563,3922,660+16.6%
Income tax907937693-3.2%
Effective tax rate22.9%27.6%26.1%
Net income2,8892,3001,785+25.6%
Net margin14.4%11.8%9.9%
Diluted EPS$3.51$2.77$2.13+26.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow4,1073,7452,556+9.7%
Capital expenditure561705696-20.4%
Free cash flow3,5463,0401,860+16.6%
Free cash flow margin17.6%15.6%10.4%
Cash from investing-534-742-1,601
Cash from financing-3,389-2,793-952
Depreciation and amortisation605567545+6.7%
Share-based compensation135122125+10.7%
Buybacks1,7391,1281,308+54.2%
Dividends paid1,7891,7491,691+2.3%
Dividend per share$2.48$1.91$1.86+29.8%
Diluted shares, weighted823m829m839m-0.7%
Shares outstanding at period end813m821m830m-1.1%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity212609401-65.2%
Non-controlling interest332348405-4.6%
Debt7,9498,5498,755-7.0%
Operating lease liabilities456420397+8.6%
Other liabilities7,0976,4675,773+9.7%
Total liabilities and equity16,04616,39315,731-2.1%
Fixed assets4,4224,5824,307-3.5%
Goodwill3,2723,4103,352-4.0%
Intangible assets1,7561,8871,920-6.9%
Investments160179n/a-10.6%
Cash and equivalents1,096966775+13.5%
Receivables1,5211,5861,504-4.1%
Inventory1,9871,9342,074+2.7%
Other assets1,8321,8491,799-0.9%
Total assets16,04616,39315,731-2.1%

10-K for the year ended 31 December 2024, filed 13 February 2025: the filing.